
NYSEHealthcareMedical - Distribution
最新数据
US$238.27
+US$0.19 · +0.08%
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
常规交易时段
US$238.6
+US$0.52 · +0.22%
盘中时间采用ET。市场数据可能有所延迟。
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
日内区间
当前US$238.6
52周区间
当前US$238.6
盘中时间采用ET。市场数据可能有所延迟。
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
日内区间
当前US$238.6
52周区间
当前US$238.6
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2026财年 | 2025财年 | 2024财年 | 2023财年 | 2022财年 |
|---|---|---|---|---|---|
| 营收 | 2542.48亿 USD | 2225.78亿 USD | 2268.27亿 USD | 2049.79亿 USD | 1813.26亿 USD |
| 销货成本 | 2444.74亿 USD | 2144.1亿 USD | 2194.13亿 USD | 1981.05亿 USD | 1748.42亿 USD |
| 毛利 | 97.74亿 USD | 81.68亿 USD | 74.14亿 USD | 68.89亿 USD | 64.84亿 USD |
| 销售、一般及管理费用 | 61.32亿 USD | 53.82亿 USD | 50亿 USD | 48亿 USD | 45.12亿 USD |
| 营业费用 | 71.61亿 USD | 58.93亿 USD | 61.71亿 USD | 61.22亿 USD | 70.91亿 USD |
| 利息支出 | 3.48亿 USD | 2.15亿 USD | 5100万 USD | 8400万 USD | 1.47亿 USD |
| 折旧和摊销 | 9.56亿 USD | 7.9亿 USD | 7.1亿 USD | 6.92亿 USD | 6.92亿 USD |
| 营业利润 | 26.13亿 USD | 22.75亿 USD | 12.43亿 USD | 7.52亿 USD | −6.07亿 USD |
| 净利润 | 17.14亿 USD | 15.61亿 USD | 8.52亿 USD | 3.3亿 USD | −9.38亿 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$273.22
上涨空间 14.51%年度分割调整后的每股现金分配。
US$2.0326
2025年(完整年度)+4.8% 自从 2020
2026年(部分年度):US$2.053
US$1.9388
2,020
US$1.9583
2,021
US$1.9779
2,022
US$1.9975
2,023
US$2.0326
2,025
US$2.053
2,026*
* 在现有股息历史记录中,该日历年仅包含部分期间。
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年10月1日 | US$0.5158Quarterly | 2026年10月1日 | 2026年10月15日 |
股息 | 2026年7月1日 | US$0.5158Quarterly | 2026年7月1日 | 2026年7月15日 |
股息 | 2026年4月1日 | US$0.5107Irregular | 2026年4月1日 | 2026年4月15日 |
股息 | 2026年1月2日 | US$0.5107Quarterly | 2026年1月2日 | 2026年1月15日 |
股息 | 2025年10月1日 | US$0.5107Quarterly | 2025年10月1日 | 2025年10月15日 |
股息 | 2025年7月1日 | US$0.5107Quarterly | 2025年7月1日 | 2025年7月15日 |
除息 2026年10月1日
US$0.5158
Quarterly
2026年10月1日登记 · 支付日 2026年10月15日
除息 2026年7月1日
US$0.5158
Quarterly
2026年7月1日登记 · 支付日 2026年7月15日
除息 2026年4月1日
US$0.5107
Irregular
2026年4月1日登记 · 支付日 2026年4月15日
除息 2026年1月2日
US$0.5107
Quarterly
2026年1月2日登记 · 支付日 2026年1月15日
除息 2025年10月1日
US$0.5107
Quarterly
2025年10月1日登记 · 支付日 2025年10月15日
除息 2025年7月1日
US$0.5107
Quarterly
2025年7月1日登记 · 支付日 2025年7月15日
报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T1068.29亿0.08%130.34万亿 JPY0.09%JP¥122,950+0.08%
Vanguard Morningstar Total Stock Market ETFVTI17.46亿0.07%2.3万亿 USD0.03%US$380.81-0.20%
Vanguard S&P 500 ETFVOO14.59亿0.08%1.8万亿 USD0.03%US$714.15-0.14%
Vanguard Morningstar Mid-Cap ETFVO11.89亿0.52%2264亿 USD0.03%US$80.835-0.11%
iShares Core S&P 500 ETFIVV7.37亿0.08%8964.4亿 USD0.03%US$780.36-0.14%
State Street SPDR S&P 500 ETFSPY6.74亿0.08%8216.79亿 USD0.09%US$776.94-0.15%
Vanguard Morningstar Value ETFVTV5.25亿0.20%2624亿 USD0.03%US$220.45-0.44%
State Street Health Care Select Sector SPDR ETFXLV3.92亿0.89%443.1亿 USD0.08%US$169.71-1.33%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLVAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。